Testimonials
“I have worked with the NTA team for eighteen months on a feasibility study. I have found the NTA team to be very supportive, efficient and highly professional. They have a thorough understanding of the requirements for managing GCP compliant clinical trials and I have no hesitation in recommending them as a CRO.”
Marie-Laure Vial, PhD
Research Fellow, Griffith University, Qld
“NTA is a dedicated and cost efficient partner for the development of our CNS drug. The management team understands the needs of small to med-size biotech companies and has the expertise to implement a successful clinical development plan that is a win for the Patient, the Investigator, NTA and the Sponsor.”
Robert Niecestro, PhD
Head of Regulatory Affairs, ES Therapeutics
“I ran a large, multi-centre, NHMRC funded RCT covering both Australian and international sites. The team at NTA were wonderful and delivered excellent high quality care and attention to all facets of the trial process, including management of ethics, site communications, risk-based monitoring, review of finances, executive and DSMB meetings, and the logistics of trial completion with database clean for final analysis. I can highly recommend NTA for any future trials.”
Prof. Christopher Bladin, Neurologist
Director, Victoria Stroke Telemedicine (VST) Service
Adjunct Professor, Monash University
“Cortexyme selected NTA as our operational partner to advance our new drug candidate in Australia. The region is very attractive to clinical research and offers significant regulatory and cost related advantages and efficiencies especially in early stage drug development. The NTA team partnered with Cortexyme and offered guidance and tactical support throughout all stages of clinical project planning and execution. All members that were assigned to our projects are highly competent, collaborative and extremely well represent Cortexyme company’s values and our scientific research goals. We are very pleased to continue our collaboration with the NTA CRO and look forward to future projects and advancing science in the region and globally. We also recommend this highly skilled group to new clients who look to expand their research into Australia.”
Joanna Bolger, MS
VP, Clinical Operations, Cortexyme
“I have worked with NTA on a number of investigator led clinical trials over many years. Their team of project managers and coordinators have been experienced, proactive, responsive, and highly organised. These attributes are critical to the success of such studies.”
A/Prof Nawaf Yassi, Neurologist
RMH, Joint Lab Head – WEHI
“NTA brings together researchers and trial sponsors across a range of neurological conditions and allows Australia to remain at the forefront of research into these acute and degenerative diseases. Small biotechs, large pharma, researchers, patients and indeed the whole Australian community benefit from this collaboration.”
A/Prof Michael Wodward, Neurologist
Director-Aged Care Research, Director-Memory Clinic
Director-Wound Clinic, Austin Health
“NTA is Australia’s foremost not-for-profit contract research organisation that specialises in research support for Dementia Trials Australia. Dementia Trials Australia has an integral relationship with NTA’s clinical and administrative staff. NTA’s key role is to help attract clinical trials to Australia. With increasing complexity of Dementia Clinical Trials, NTA provides invaluable support to our clinical trial sites. NTA supports Dementia Trials Australia Annual scientific meeting.”
Dr Chrys Pulle
Chair, Dementia Trials Australia
“I worked with NTA towards the end of our clinical trial. I was very pleased with the responsiveness of NTA and intensive support we received from management when we had a critical deliverable. During the time of shutting down the study and moving to database lock, the NTA team that pitched in to deliver was superb!”
Tara Lehner, MS, PMP
Vice President, Clinical Operations, Immune Bio
“As Chairperson of the executive committee of the Australia and New Zealand Movement Disorders Clinical Research Network (ANZ-MD-CRN) I would like to express appreciation of, and endorsement for, the exceptional support provided to our committee and network members by NTA. Not only does NTA provide critical administrative support for our network but also endeavours to seek out new clinical trials in Parkinson’s disease and other movement disorders relevant to our interests and expertise.
Prof Tim Anderson
Chair ANZ-MD-CRN